IIM
GSK icon

Ipswich Investment Management’s GSK GSK Stock Holding History

Ipswich Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$434K Sell
8,270
-256
-3% -$13.5K 0.09% 137
2026
Q1 		$471K Hold
8,526
– – 0.11% 130
2025
Q4 		$418K Sell
8,526
-438
-5% -$20.4K 0.1% 134
2025
Q3 		$387K Hold
8,964
– – 0.09% 135
2025
Q2 		$344K Buy
8,964
+860
+11% +$32.9K 0.08% 141
2025
Q1 		$314K Sell
8,104
-240
-3% -$8.79K 0.08% 143
2024
Q4 		$282K Sell
8,344
-48
-0.6% -$1.73K 0.07% 159
2024
Q3 		$343K Hold
8,392
– – 0.08% 146
2024
Q2 		$323K Hold
8,392
– – 0.08% 152
2024
Q1 		$360K Hold
8,392
– – 0.08% 147
2023
Q4 		$311K Sell
8,392
-1,100
-12% -$39.5K 0.08% 151
2023
Q3 		$344K Hold
9,492
– – 0.09% 139
2023
Q2 		$338K Hold
9,492
– – 0.09% 147
2023
Q1 		$338K Buy
9,492
+300
+3% +$10.5K 0.09% 143
2022
Q4 		$323K Hold
9,192
– – 0.09% 144
2022
Q3 		$271K Buy
9,192
+840
+10% +$31.8K 0.09% 151
2022
Q2 		$454K Buy
8,352
+220
+3% +$12.1K 0.13% 127
2022
Q1 		$443K Sell
8,132
-880
-10% -$47.8K 0.11% 135
2021
Q4 		$497K Sell
9,012
-2,592
-22% -$135K 0.12% 129
2021
Q3 		$554K Sell
11,604
-28,340
-71% -$1.42M 0.14% 121
2021
Q2 		$1.99M Buy
39,944
+480
+1% +$23.1K 0.51% 59
2021
Q1 		$1.76M Sell
39,464
-30,212
-43% -$1.37M 0.5% 61
2020
Q4 		$3.21M Sell
69,676
-4,324
-6% -$199K 0.96% 36
2020
Q3 		$3.48M Buy
74,000
+2,984
+4% +$150K 1.12% 32
2020
Q2 		$3.62M Buy
71,016
+360
+0.5% +$18.5K 1.25% 23
2020
Q1 		$3.35M Sell
70,656
-2,962
-4% -$158K 1.32% 23
2019
Q4 		$4.32M Buy
73,618
+1,020
+1% +$56.7K 1.27% 24
2019
Q3 		$3.87M Buy
72,598
+440
+0.6% +$22.6K 1.23% 27
2019
Q2 		$3.61M Buy
72,158
+5,408
+8% +$271K 1.15% 30
2019
Q1 		$3.49M Buy
66,750
+4,154
+7% +$208K 1.14% 29
2018
Q4 		$2.99M Buy
62,596
+2,544
+4% +$125K 1.1% 31
2018
Q3 		$3.02M Buy
60,052
+4,704
+8% +$239K 1.02% 31
2018
Q2 		$2.79M Buy
55,348
+37,656
+213% +$1.9M 1.28% 28
2018
Q1 		$864K Buy
17,692
+128
+0.7% +$5.96K 0.36% 69
2017
Q4 		$779K Sell
17,564
-928
-5% -$42.9K 0.33% 75
2017
Q3 		$938K Buy
18,492
+1,116
+6% +$56.6K 0.42% 62
2017
Q2 		$937K Buy
17,376
+112
+0.6% +$5.97K 0.44% 63
2017
Q1 		$910K Hold
17,264
– – 0.4% 67
2016
Q4 		$831K Sell
17,264
-2,760
-14% -$136K 0.38% 68
2016
Q3 		$1.08M Buy
20,024
+1,140
+6% +$62.5K 0.53% 56
2016
Q2 		$1.02M Sell
18,884
-800
-4% -$42.1K 0.51% 58
2016
Q1 		$1.05M Hold
19,684
– – 0.5% 57
2015
Q4 		$993K Sell
19,684
-560
-3% -$28.5K 0.45% 55
2015
Q3 		$973K Sell
20,244
-72
-0.4% -$3.75K 0.46% 55
2015
Q2 		$1.06M Sell
20,316
-880
-4% -$49.5K 0.48% 57
2015
Q1 		$1.22M Sell
21,196
-1,200
-5% -$68.8K 0.54% 53
2014
Q4 		$1.2M Sell
22,396
-28,272
-56% -$1.58M 0.51% 51
2014
Q3 		$2.91M Sell
50,668
-14,702
-22% -$901K 1.24% 33
2014
Q2 		$4.37M Sell
65,370
-9
-0% -$609 1.69% 20
2014
Q1 		$4.37M Buy
65,379
+2,990
+5% +$202K 1.88% 18
2013
Q4 		$4.16M Sell
62,389
-24
-0% -$1.56K 1.74% 18
2013
Q3 		$3.91M Sell
62,413
-914
-1% -$58.8K 1.76% 18
2013
Q2 		$3.96M Buy
+63,327
New +$4.02M 1.71% 18

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Ipswich Investment Management's GSK Position: Q2 2026 in Review

Ipswich Investment Management reduced its GSK (GSK) stake by 3% in Q2 2026, selling an estimated $13.5K and leaving 8,270 shares worth $434K. The position accounts for 0.09% of the portfolio, ranked #137.

Ipswich Investment Management first reported a position in GSK in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.37M in Q2 2014. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Ipswich Investment Management held 8,270 shares of GSK worth $434K as of Q2 2026.
  • Ipswich Investment Management sold 256 GSK shares in Q2 2026, an estimated $13.5K.
  • GSK made up 0.09% of Ipswich Investment Management's portfolio in Q2 2026, its #137 holding.
  • Ipswich Investment Management first reported a position in GSK in Q2 2013 and has held it in 53 quarters since.
  • Ipswich Investment Management's GSK position peaked at $4.37M in Q2 2014.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Ipswich Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.